As of 2024-12-14, the EV/EBITDA ratio of Vireo Health International Inc (VREO.CN) is
20.19.
EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. VREO.CN's latest enterprise value
is 163.82 mil CAD. VREO.CN's TTM EBITDA according to its financial statements is
8.12 mil CAD. Dividing these 2
quantities gives us the above VREO.CN EV/EBITDA ratio.
|
Range |
Selected |
| Trailing P/E multiples |
10.9x - 13.4x |
12.2x |
| Forward P/E multiples |
11.3x - 15.0x |
13.2x |
| Fair Price |
0.26 - 0.36 |
0.31 |
| Upside |
-31.5% - -5.8% |
-17.4% |